ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

SPRO Spero Therapeutics Inc

1.65
0.04 (2.48%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Spero Therapeutics Inc SPRO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.04 2.48% 1.65 09:00:00
始値 安値 高値 終値 前日終値
1.63 1.62 1.6494 1.63 1.61
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/0622:05GLOBESpero Therapeutics to Provide Business Update and Report..
2024/2/2822:05GLOBESpero Therapeutics Announces Clearance of IND for SPR206 to..
2024/2/2622:05GLOBESpero Therapeutics to Present at Cowen’s 44th Annual..
2024/2/1006:05EDGAR2Form 8-K - Current report
2024/2/0610:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0610:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0610:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0610:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0610:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0606:50EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0106:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
2024/1/0820:07EDGAR2Form 8-K - Current report
2024/1/0522:11EDGAR2Form 8-K - Current report
2024/1/0522:05GLOBESpero Therapeutics Provides Corporate Update and 2024..
2024/1/0506:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0222:13EDGAR2Form 8-K - Current report
2024/1/0222:05GLOBESpero Therapeutics Announces First Patient, First Visit for..
2023/11/1606:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1606:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/1406:50EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/11/1406:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/11/1406:13EDGAR2Form 8-K - Current report
2023/11/1406:05GLOBESpero Therapeutics Announces Third Quarter 2023 Operating..
2023/11/1406:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1320:45IHMARKETNEWSMonday’s Wall Street Highlights: Boeing, Novo Nordisk,..
2023/11/0622:05GLOBESpero Therapeutics to Provide Business Update and Report..
2023/11/0205:05GLOBESpero Therapeutics to Present at Upcoming November Investor..
2023/11/0121:10EDGAR2Form 8-K - Current report
2023/11/0121:05GLOBESpero Therapeutics Appoints Esther Rajavelu as Chief..
2023/11/0105:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
2023/10/1705:01EDGAR2Form 8-K/A - Current report: [Amend]
2023/10/1106:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1106:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1021:28EDGAR2Form 8-K - Current report
2023/9/3005:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
2023/9/2105:05GLOBESpero Therapeutics to Present at Cantor’s Global Healthcare..
2023/9/1606:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0621:05GLOBESpero Therapeutics to Present at H.C. Wainwright 25th Annual..
2023/9/0205:11EDGAR2Form ARS - Annual Report to Security Holders
2023/9/0205:08EDGAR2Form DEF 14A - Other definitive proxy statements
2023/9/0105:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
2023/8/3105:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3105:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3105:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3005:16EDGAR2Form 144 - Report of proposed sale of securities
2023/8/2306:27EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/8/1105:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/8/1105:17EDGAR2Form 8-K - Current report
2023/8/1105:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:05GLOBESpero Therapeutics Announces Second Quarter 2023 Operating..

最近閲覧した銘柄

Delayed Upgrade Clock